Skip to main content

Lobbying activity

Who's lobbying Congress, for whom, and on what, from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 1,397 filings

Top spenders & firms Spend by issue

Clear
Q3
CHARTWELL STRATEGY GROUP LLC for AMAZON.COM (FRA PILLPACK AN AMAZON COMPANY)
3rd Quarter (July 1 - Sep 30) 2025 · New Hampshire · House · Senate · $40,000.00 income
Pharmacy
View →
Q3
CHILDREN'S HOSPITAL AND HEALTH SYSTEM, INC. for CHILDREN'S HOSPITAL AND HEALTH SYSTEM, INC.
3rd Quarter (July 1 - Sep 30) 2025 · Wisconsin · House · Senate
Budget/Appropriations, Medicare/Medicaid, Pharmacy
View →
Q3
MICHAEL BEST STRATEGIES LLC for AMERICAN KRATOM ASSOCIATION
3rd Quarter (July 1 - Sep 30) 2025 · Virginia · $40,000.00 income
Pharmacy, Health Issues
View →
Q3
FEDERAL HEALTH POLICY STRATEGIES for BRIGHTSPRING HEALTH SERVICES
3rd Quarter (July 1 - Sep 30) 2025 · Kentucky · House · Senate · $80,000.00 income
Medicare/Medicaid, Pharmacy, Health Issues
View →
Q3
VAN SCOYOC ASSOCIATES for ZEBRA TECHNOLOGIES CORP.
3rd Quarter (July 1 - Sep 30) 2025 · New Jersey · $30,000.00 income
Consumer Issues/Safety/Products, Pharmacy
View →
Q3
LMH STRATEGIC SOLUTIONS for REGENXBIO INC.
3rd Quarter (July 1 - Sep 30) 2025 · Maryland · House · Senate · $60,000.00 income
Pharmacy, Medicare/Medicaid
View →
Q3
LMH STRATEGIC SOLUTIONS for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $30,000.00 income
Medicare/Medicaid, Pharmacy
View →
Q3
LMH STRATEGIC SOLUTIONS for NEUROCRINE BIOSCIENCES, INC.
3rd Quarter (July 1 - Sep 30) 2025 · California · House · Senate · $30,000.00 income
Pharmacy, Medicare/Medicaid
View →
Q3
LMH STRATEGIC SOLUTIONS for INCYTE CORPORATION
3rd Quarter (July 1 - Sep 30) 2025 · Delaware · House · Senate · $70,000.00 income
Pharmacy, Medicare/Medicaid
View →
Q3
LMH STRATEGIC SOLUTIONS for HARMONY BIOSCIENCES
3rd Quarter (July 1 - Sep 30) 2025 · Pennsylvania · House · Senate · $30,000.00 income
Pharmacy, Medicare/Medicaid
View →
Q3
LMH STRATEGIC SOLUTIONS for GLAXOSMITHKLINE LLC
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $40,000.00 income
Health Issues, Pharmacy
View →
Q3
LMH STRATEGIC SOLUTIONS for EXELIXIS, INC.
3rd Quarter (July 1 - Sep 30) 2025 · California · House · Senate · $30,000.00 income
Pharmacy, Medicare/Medicaid
View →
Q3
LMH STRATEGIC SOLUTIONS for BIOMARIN PHARMACEUTICAL, INC.
3rd Quarter (July 1 - Sep 30) 2025 · California · House · Senate · $30,000.00 income
Medicare/Medicaid, Pharmacy
View →
Q3
LMH STRATEGIC SOLUTIONS for AVADEL PHARMACEUTICALS, PLC
3rd Quarter (July 1 - Sep 30) 2025 · House · Senate · $60,000.00 income
Pharmacy
View →
Q3
LMH STRATEGIC SOLUTIONS for ARDELYX, INC.
3rd Quarter (July 1 - Sep 30) 2025 · California · House · Senate · $30,000.00 income
Pharmacy, Medicare/Medicaid
View →
Q3
LMH STRATEGIC SOLUTIONS for ACADIA PHARMACEUTICALS
3rd Quarter (July 1 - Sep 30) 2025 · California · House · Senate · $30,000.00 income
Medicare/Medicaid, Pharmacy
View →
Q3
THE VOGEL GROUP for NEPHRON PHARMACEUTICALS CORPORATION
3rd Quarter (July 1 - Sep 30) 2025 · South Carolina · $45,000.00 income
Pharmacy
View →
Q3
HARMONY BIOSCIENCES for HARMONY BIOSCIENCES
3rd Quarter (July 1 - Sep 30) 2025 · Pennsylvania · House · Senate
Pharmacy
View →
Q3
HORIZON BLUE CROSS BLUE SHIELD OF NEW JERSEY for HORIZON BLUE CROSS BLUE SHIELD OF NEW JERSEY
3rd Quarter (July 1 - Sep 30) 2025 · New Jersey · House · Senate
Health Issues, Medicare/Medicaid, Pharmacy
View →
Q3
FORBES-TATE for CALIFORNIA LIFE SCIENCES ASSOCIATION
3rd Quarter (July 1 - Sep 30) 2025 · California · House · Senate · $40,000.00 income
Manufacturing, Medical/Disease Research/Clinical Labs, Health Issues, Medicare/Medicaid
View →
Q3
CHECKMATE GOVERNMENT RELATIONS for GSK
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · $50,000.00 income
Health Issues, Pharmacy
View →
Q3
TWENTY-FIRST CENTURY GROUP, INC. for CARDINAL HEALTH, INC.
3rd Quarter (July 1 - Sep 30) 2025 · Ohio · House · Senate · $24,000.00 income
Pharmacy, Disaster Planning/Emergencies, Health Issues, Budget/Appropriations
View →
Q3
WINNING STRATEGIES WASHINGTON for KALEO
3rd Quarter (July 1 - Sep 30) 2025 · Virginia · House · Senate · $10,000.00 income
Health Issues, Pharmacy, Defense, Budget/Appropriations
View →
Q3
MANATOS & MANATOS for VANDA PHARMACEUTICALS INC
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate
Pharmacy
View →
Q3
INVARIANT LLC for SK AMERICAS, INC.
3rd Quarter (July 1 - Sep 30) 2025 · New York · House · Senate · $140,000.00 income
Environment/Superfund, Science/Technology, Pharmacy, Energy/Nuclear
View →
Previous Page 23 of 56 Next

Source: federal Lobbying Disclosure Act filings. A filing's bill references are parsed from its activity descriptions, so a bill page shows the filings that named it.

Report a problem